NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg (as film-coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg+ Aspirin IP 75mg (As Gastro-resistant tablet) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Pvt. Ltd. (Marketer)

Mar 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 17, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg (as film coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg+ Aspirin IP 75mg (As Gastro-resistant tablet) for M/s Safetab Life Science (Manufacturer) & M/s Corona Remedies Pvt. Ltd. (Marketer).

It states that the price for each hard gelatin capsule containing: Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg (as film-coated tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg + Aspirin IP 75mg has been fixed at Rs. 8.80/- excluding GST.

[Notification no. - 19(5048)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT